In London, BioAge CBO & Head of Brain Aging Peng Leong joined biotech & pharma leaders on a panel entitled “Cardiometabolic Disease & Obesity: Unlocking Unique Partnering Opportunities for Biotech.”
March 21, 2024
Longevity goes to Washington
BioAge leadership participated in A4LI's DC fly-in event, and CEO Kristen Fortney spoke at the first-ever briefing on longevity science on Capitol Hill.
February 15, 2024
Trading floor takeover at NYSE
BioAge takes over the NYSE Trading Floor! Thanks to the team at NYSE for helping us continue the celebration of our $170M Series D to bring our lead compound into Phase 2 clinical trials and advance our pipeline.
February 14, 2024
NASDAQ tower announcement
On the big screen in Times Square, NASDAQ helps us celebrate our $170M Series D to accelerate clinical development for obesity therapeutics.